Related references
Note: Only part of the references are listed.miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma
Cecile Gastaldi et al.
CARCINOGENESIS (2014)
Extensive sequence variation in the 3′ untranslated region of the KRAS gene in lung and ovarian cancer cases
Minlee Kim et al.
CELL CYCLE (2014)
Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma
Y. Zhang et al.
CELL DEATH AND DIFFERENTIATION (2014)
Association Study of the let-7 miRNA-Complementary Site Variant in the 3′ Untranslated Region of the KRAS Gene in Stage III Colon Cancer (NCCTG N0147 Clinical Trial)
Dan Sha et al.
CLINICAL CANCER RESEARCH (2014)
MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2
Wen-Ting Liao et al.
JOURNAL OF PATHOLOGY (2014)
Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer
Hong Jin et al.
MEDICAL ONCOLOGY (2014)
EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis
M. Tanaka et al.
ONCOGENE (2014)
Transcriptome-Wide Analysis of UTRs in Non-Small Cell Lung Cancer Reveals Cancer-Related Genes with SNV-Induced Changes on RNA Secondary Structure and miRNA Target Sites
Radhakrishnan Sabarinathan et al.
PLOS ONE (2014)
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Trials 9708 and 9905
Larissa J. Lee et al.
PLOS ONE (2014)
A let-7 KRAS rs712 polymorphism increases colorectal cancer risk
Xin-Min Pan et al.
TUMOR BIOLOGY (2014)
The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3′-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients
Ana Sebio et al.
PHARMACOGENETICS AND GENOMICS (2013)
A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer
Zhao-Hui Li et al.
TUMOR BIOLOGY (2013)
KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study
Jasmina-Ziva Cerne et al.
BMC CANCER (2012)
Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
Janne B. Kjersem et al.
BMC CANCER (2012)
A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis
Olga Grechukhina et al.
EMBO MOLECULAR MEDICINE (2012)
Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma
Wen-Yi Wang et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene
Miljana Tanic et al.
PLOS ONE (2012)
A let-7 microRNA-binding site polymorphism in 3 '-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy
W. Zhang et al.
ANNALS OF ONCOLOGY (2011)
miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras
Ki-Hyuk Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing
Paul D. P. Pharoah et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNA therapeutics in preclinical cancer models
Minlee Kim et al.
LANCET ONCOLOGY (2011)
A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
Trupti Paranjape et al.
LANCET ONCOLOGY (2011)
A Variant in a MicroRNA complementary site in the 3′ UTR of the KIT oncogene increases risk of acral melanoma
S. E. Godshalk et al.
ONCOGENE (2011)
A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
Elena Ratner et al.
CANCER RESEARCH (2010)
miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
Shuangni Yu et al.
CANCER RESEARCH (2010)
KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer
H. H. Nelson et al.
LUNG CANCER (2010)
A SNP in a let-7 microRNA Complementary Site in the KRAS 3′ Untranslated Region Increases Non-Small Cell Lung Cancer Risk
Lena J. Chin et al.
CANCER RESEARCH (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
Share Paper
